3.5 Idiopathic pulmonary fibrosis
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
Antifibrotics
Pirfenidone
- Esbriet® Capsules 267mg
Note:
- Hospital only - Initiation in tertiary care, subsequently shared care with secondary care and homecare. (NHS England Specialised Commissioning).
- Use as per NICE TA504: Pirfenidone for treating idiopathic pulmonary fibrosis (February 2018)
Return to Chapter: 3. Respiratory System
Last updated by: Dupe Fagbenro on 04-05-2018 18:18
-
BNF
-
NICE
-
Summary of product characteristics
